News|Articles|September 24, 2026

Where LC-MS/MS Meets the ER Clock: The Case for Paper Spray-MS in Acute Drug Toxicity Screening

Author(s)Vincenzo Abbate, John Chasse

Paper spray-mass spectrometry vs. liquid chromtography-tandem mass spectrometry (LC-MS/MS): Can rapid screening rival the gold standard in ER drug testing?

For forensic and clinical toxicologists, the gold-standard analytical technique is not always the one you can use when it matters most.

Related to this article

October 6th, 2026

Industry Roundup: Shimadzu Europa Names Florian Geistmann Managing Director as Jürgen Semmler Retires

Florian Geistmann succeeded retiring Jürgen Semmler as Shimadzu Europa managing director on October 1.

October 6th, 2026

LC-MS Maps Grapevine Chemical Diversity

Liquid chromatography-mass spectrometry (LC-MS) profiling reveals chemical diversity across grapevine varieties.

October 6th, 2026

LC-MS, NMR Map Infant Urinary Metabolic Profiles

Liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) link perinatal factors to infant urinary metabolite changes.

October 6th, 2026

The LCGC Blog: NIST Reference Materials

This LCGC Blog installment explains how NIST categorizes and certifies reference materials, and why they underpin reliable results in science and medicine.

October 6th, 2026

Automated Workflow Paves Way for High-Throughput Reproducible Operations—Trastuzumab Glycosylation Profiling as a Case Study

Comparing manual and automated N-glycan profiling of a trastuzumab biosimilar, researchers found that both workflows detected the same glycan types, but automation gave more reproducible results (mean CV of about 5.7% vs. 7.95%), making it better suited to high-throughput analysis in biopharmaceutical development.